Safety, tolerability, and immunogenicity of INO-4500, a synthetic DNA-based vaccine against Lassa virus, in a phase 1b clinical trial in healthy Ghanaian adults.

Saved in:
Bibliographic Details
Title: Safety, tolerability, and immunogenicity of INO-4500, a synthetic DNA-based vaccine against Lassa virus, in a phase 1b clinical trial in healthy Ghanaian adults.
Authors: Koram KA; Department of Epidemiology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana., Walker KA; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States., Orizu B; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States., Marrero I; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States., Boyer J; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States., Yang S; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States., Broderick KE; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States., Kusi KA; Department of Immunology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana., Kyei-Baafour E; Department of Immunology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana., Ofori EA; Department of Immunology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana., Pobee A; Department of Immunology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana., Adu-Amankwah S; Department of Epidemiology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana., Amoakoh-Coleman M; Department of Epidemiology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana., Amoakoh HB; Department of Epidemiology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana.; Department of Global Public Health and Bioethics, Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht University, Utrecht, Netherlands., Abuaku B; Department of Epidemiology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana., Badji E; Department of Epidemiology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana., Ntiri M; Department of Epidemiology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana., Quaye L; Department of Epidemiology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana., Morrow MP; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States., Sylvester AJ; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States., Reuschel EL; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States., Gillespie E; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States., Liebowitz D; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States., Humeau LM; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States.
Source: Frontiers in immunology [Front Immunol] 2025 Oct 24; Vol. 16, pp. 1658549. Date of Electronic Publication: 2025 Oct 24 (Print Publication: 2025).
Publication Type: Journal Article; Clinical Trial, Phase I; Randomized Controlled Trial
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41208990
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety, tolerability, and immunogenicity of INO-4500, a synthetic DNA-based vaccine against Lassa virus, in a phase 1b clinical trial in healthy Ghanaian adults.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Koram+KA%22">Koram KA</searchLink>; Department of Epidemiology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana.<br /><searchLink fieldCode="AU" term="%22Walker+KA%22">Walker KA</searchLink>; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States.<br /><searchLink fieldCode="AU" term="%22Orizu+B%22">Orizu B</searchLink>; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States.<br /><searchLink fieldCode="AU" term="%22Marrero+I%22">Marrero I</searchLink>; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States.<br /><searchLink fieldCode="AU" term="%22Boyer+J%22">Boyer J</searchLink>; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States.<br /><searchLink fieldCode="AU" term="%22Yang+S%22">Yang S</searchLink>; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States.<br /><searchLink fieldCode="AU" term="%22Broderick+KE%22">Broderick KE</searchLink>; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States.<br /><searchLink fieldCode="AU" term="%22Kusi+KA%22">Kusi KA</searchLink>; Department of Immunology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana.<br /><searchLink fieldCode="AU" term="%22Kyei-Baafour+E%22">Kyei-Baafour E</searchLink>; Department of Immunology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana.<br /><searchLink fieldCode="AU" term="%22Ofori+EA%22">Ofori EA</searchLink>; Department of Immunology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana.<br /><searchLink fieldCode="AU" term="%22Pobee+A%22">Pobee A</searchLink>; Department of Immunology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana.<br /><searchLink fieldCode="AU" term="%22Adu-Amankwah+S%22">Adu-Amankwah S</searchLink>; Department of Epidemiology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana.<br /><searchLink fieldCode="AU" term="%22Amoakoh-Coleman+M%22">Amoakoh-Coleman M</searchLink>; Department of Epidemiology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana.<br /><searchLink fieldCode="AU" term="%22Amoakoh+HB%22">Amoakoh HB</searchLink>; Department of Epidemiology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana.; Department of Global Public Health and Bioethics, Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht University, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22Abuaku+B%22">Abuaku B</searchLink>; Department of Epidemiology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana.<br /><searchLink fieldCode="AU" term="%22Badji+E%22">Badji E</searchLink>; Department of Epidemiology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana.<br /><searchLink fieldCode="AU" term="%22Ntiri+M%22">Ntiri M</searchLink>; Department of Epidemiology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana.<br /><searchLink fieldCode="AU" term="%22Quaye+L%22">Quaye L</searchLink>; Department of Epidemiology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana.<br /><searchLink fieldCode="AU" term="%22Morrow+MP%22">Morrow MP</searchLink>; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States.<br /><searchLink fieldCode="AU" term="%22Sylvester+AJ%22">Sylvester AJ</searchLink>; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States.<br /><searchLink fieldCode="AU" term="%22Reuschel+EL%22">Reuschel EL</searchLink>; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States.<br /><searchLink fieldCode="AU" term="%22Gillespie+E%22">Gillespie E</searchLink>; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States.<br /><searchLink fieldCode="AU" term="%22Liebowitz+D%22">Liebowitz D</searchLink>; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States.<br /><searchLink fieldCode="AU" term="%22Humeau+LM%22">Humeau LM</searchLink>; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2025 Oct 24; Vol. 16, pp. 1658549. <i>Date of Electronic Publication: </i>2025 Oct 24 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase I; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41208990
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2025.1658549
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1658549
    Titles:
      – TitleFull: Safety, tolerability, and immunogenicity of INO-4500, a synthetic DNA-based vaccine against Lassa virus, in a phase 1b clinical trial in healthy Ghanaian adults.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Koram KA
      – PersonEntity:
          Name:
            NameFull: Walker KA
      – PersonEntity:
          Name:
            NameFull: Orizu B
      – PersonEntity:
          Name:
            NameFull: Marrero I
      – PersonEntity:
          Name:
            NameFull: Boyer J
      – PersonEntity:
          Name:
            NameFull: Yang S
      – PersonEntity:
          Name:
            NameFull: Broderick KE
      – PersonEntity:
          Name:
            NameFull: Kusi KA
      – PersonEntity:
          Name:
            NameFull: Kyei-Baafour E
      – PersonEntity:
          Name:
            NameFull: Ofori EA
      – PersonEntity:
          Name:
            NameFull: Pobee A
      – PersonEntity:
          Name:
            NameFull: Adu-Amankwah S
      – PersonEntity:
          Name:
            NameFull: Amoakoh-Coleman M
      – PersonEntity:
          Name:
            NameFull: Amoakoh HB
      – PersonEntity:
          Name:
            NameFull: Abuaku B
      – PersonEntity:
          Name:
            NameFull: Badji E
      – PersonEntity:
          Name:
            NameFull: Ntiri M
      – PersonEntity:
          Name:
            NameFull: Quaye L
      – PersonEntity:
          Name:
            NameFull: Morrow MP
      – PersonEntity:
          Name:
            NameFull: Sylvester AJ
      – PersonEntity:
          Name:
            NameFull: Reuschel EL
      – PersonEntity:
          Name:
            NameFull: Gillespie E
      – PersonEntity:
          Name:
            NameFull: Liebowitz D
      – PersonEntity:
          Name:
            NameFull: Humeau LM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 24
              M: 10
              Text: 2025 Oct 24
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1